China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction... Show more
A.I.dvisor indicates that over the last year, SXTC has been loosely correlated with AQST. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SXTC jumps, then AQST could also see price increases.
| Ticker / NAME | Correlation To SXTC | 1D Price Change % | ||
|---|---|---|---|---|
| SXTC | 100% | -14.58% | ||
| AQST - SXTC | 35% Loosely correlated | -3.15% | ||
| SBFM - SXTC | 31% Poorly correlated | -10.18% | ||
| SNDL - SXTC | 28% Poorly correlated | N/A | ||
| RDY - SXTC | 27% Poorly correlated | -0.15% | ||
| GELS - SXTC | 25% Poorly correlated | +0.07% | ||
More | ||||
| Ticker / NAME | Correlation To SXTC | 1D Price Change % |
|---|---|---|
| SXTC | 100% | -14.58% |
| Pharmaceuticals: Generic industry (83 stocks) | 53% Loosely correlated | -2.27% |
a developer of traditional chinese medicines
Industry PharmaceuticalsGeneric
SXTC saw its Momentum Indicator move below the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 110 similar instances where the indicator turned negative. In 108 of the 110 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SXTC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for SXTC entered a downward trend on September 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +19.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where SXTC advanced for three days, in 150 of 176 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
SXTC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.003) is normal, around the industry mean (9.032). P/E Ratio (-0.001) is within average values for comparable stocks, (-3.059). Projected Growth (PEG Ratio) (1.160) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (0.016) is also within normal values, averaging (178.797).
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 99 (best 1 - 100 worst), indicating slightly worse than average price growth. SXTC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SXTC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.